Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b
Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Intelli.b – Biosimilar Fingerprinting
Biosimilars Unveiled: A Strategic Overview of Market Opportunities and Innovation..
Read More ...Ultrasensitive bioanalysis and machine
Now Streaming On-Demand While significant advances have been made in..
Read More ...UltraSensative
Amplatto™- Ultrasensitive Bioanalysis and Machine Learning
Read More ...Amplatto
Amplatto Applications Ultra-sensitive bioanalysis, ADA, low dose PK Information Femtomolar..
Read More ...